Research programme: G protein-coupled receptor antagonists - TransTech Pharma

Drug Profile

Research programme: G protein-coupled receptor antagonists - TransTech Pharma

Alternative Names: GPCR antagonists - TransTech; Pain therapeutics - TransTech

Latest Information Update: 21 Sep 2010

Price : $50

At a glance

  • Originator TransTech Pharma
  • Class
  • Mechanism of Action G protein-coupled receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Neuropathic pain

Most Recent Events

  • 21 Sep 2010 Discontinued - Preclinical for Neuropathic pain in USA (unspecified route)
  • 20 May 2005 The programme is available for licensing (http://www.ttpharma.com)
  • 08 Jul 2004 Preclinical trials in Neuropathic pain in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top